SEC Form 4 · accession 0001144204-16-080459
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Feb 9, 2016
Accepted (ET)
Feb 10, 2016 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F1,F2 | — | Feb 9, 2016 | A | 7,500 | A | — | — | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F2These restricted stock units are scheduled to vest 100% on February 9, 2017.
- F3The restricted stock units were granted pursuant to the Issuer's 2014 Stock Incentive Plan.